Aprogen pharmaceuticals,Inc. (003060.KS)
003060.KS Stock Price Chart
Explore Aprogen pharmaceuticals,Inc. interactive price chart. Choose custom timeframes to analyze 003060.KS price movements and trends.
003060.KS Company Profile
Discover essential business fundamentals and corporate details for Aprogen pharmaceuticals,Inc. (003060.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Jan 2000
Employees
377.00
CEO
Jeong-Chool Kim
Description
Aprogen pharmaceuticals,Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-viral, anti-ulcerant, anti-epliepsy products; external agents; anti-cancer drugs; amino-acid nutrient transfusion agents; and cosmetics. The company was formerly known as Schnell Biopharmaceuticals, Inc. and changed its name to Aprogen pharmaceuticals,Inc. in April 2017. Aprogen pharmaceuticals,Inc. was founded in 1960 and is headquartered in Seongnam, South Korea.
003060.KS Financial Timeline
Browse a chronological timeline of Aprogen pharmaceuticals,Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 11 Nov 2025
Earnings released on 12 Aug 2025
EPS came in at -₩338.00 , while revenue for the quarter reached ₩14.90B .
Earnings released on 14 May 2025
EPS came in at -₩218.00 , while revenue for the quarter reached ₩16.85B .
Earnings released on 12 Mar 2025
Revenue for the quarter reached ₩22.05B .
Earnings released on 14 Nov 2024
EPS came in at -₩91.00 , while revenue for the quarter reached ₩14.53B .
Earnings released on 14 Aug 2024
EPS came in at -₩345.65 , while revenue for the quarter reached ₩15.19B .
Earnings released on 14 May 2024
EPS came in at -₩69.15 , while revenue for the quarter reached ₩15.61B .
Stock split effective on 16 Apr 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 27 Mar 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Mar 2024
EPS came in at -₩1.12K , while revenue for the quarter reached ₩22.70B .
Earnings released on 10 Nov 2023
EPS came in at -₩56.16 , while revenue for the quarter reached ₩20.13B .
Earnings released on 10 Aug 2023
EPS came in at -₩213.87 , while revenue for the quarter reached ₩27.07B .
Earnings released on 12 May 2023
EPS came in at ₩149.09 , while revenue for the quarter reached ₩17.45B .
Earnings released on 17 Mar 2023
EPS came in at -₩15.49 , while revenue for the quarter reached ₩17.08B .
Earnings released on 9 Nov 2022
EPS came in at ₩86.26 , while revenue for the quarter reached ₩16.02B .
Earnings released on 11 Aug 2022
EPS came in at ₩8.00 , while revenue for the quarter reached ₩15.23B .
Earnings released on 12 May 2022
EPS came in at ₩7.00 , while revenue for the quarter reached ₩16.86B .
Earnings released on 10 Mar 2022
EPS came in at ₩4.09 , while revenue for the quarter reached ₩14.37B .
Earnings released on 11 Nov 2021
EPS came in at ₩4.00 , while revenue for the quarter reached ₩15.16B .
Earnings released on 30 Sept 2021
EPS came in at ₩7.00 , while revenue for the quarter reached ₩14.67B .
Earnings released on 31 Mar 2021
EPS came in at ₩4.88 , while revenue for the quarter reached ₩12.28B .
Earnings released on 31 Dec 2020
EPS came in at -₩2.10 , while revenue for the quarter reached ₩12.57B .
Earnings released on 30 Sept 2020
EPS came in at ₩12.00 , while revenue for the quarter reached ₩13.41B .
003060.KS Stock Performance
Access detailed 003060.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.